Horber F F, Frey F J, Descoeudres C, Murray A T, Reubi F C
Antimicrob Agents Chemother. 1986 Apr;29(4):614-9. doi: 10.1128/AAC.29.4.614.
Amoxicillin and clavulanic acid are prescribed as a fixed drug combination. The purpose of the present study was to assess the influence of various degrees of renal insufficiency (glomerular filtration rate [GFR], less than 5 to greater than 75 ml/min per 1.73 m2) on the pharmacokinetics of amoxicillin and clavulanic acid following oral (500 and 125 mg of amoxicillin and clavulanic acid, respectively) and intravenous (1,000 and 200 mg, respectively) dosing. The volume of distribution and the systemic availability were independent of the renal function, while the total body clearance and the renal and the nonrenal clearance of amoxicillin and clavulanic acid decreased with decreasing renal function. The decrease in the total body clearance was more pronounced for amoxicillin than for clavulanic acid. This explains the increase in the ratio of the area under the plasma concentration versus time curve of amoxicillin to that of clavulanic acid with decreasing glomerular filtration rate after oral dosing; for example for a GFR of 75 ml/min, the ratio of amoxicillin to clavulanic acid was 4.9 +/- 1.2; for a GFR of 35 to 75 ml/min, 5.3 +/- 2.4; for a GFR of 10 to 35 ml/min, 11.9 +/- 5.8; for a GFR of 5 to 10 ml/min, 13.4 +/- 9.1; and for patients on hemodialysis, 14.7 +/- 5.3. Dosage recommendations are suggested which prevent undue accumulations of amoxicillin while maintaining adequate concentrations of clavulanic acid.
阿莫西林和克拉维酸作为一种固定的药物组合被开具处方。本研究的目的是评估不同程度的肾功能不全(肾小球滤过率[GFR],每1.73平方米小于5至大于75毫升/分钟)对口服(分别为500毫克和125毫克阿莫西林和克拉维酸)和静脉注射(分别为1000毫克和200毫克)给药后阿莫西林和克拉维酸药代动力学的影响。分布容积和全身可用性与肾功能无关,而阿莫西林和克拉维酸的总体清除率以及肾清除率和非肾清除率随肾功能下降而降低。阿莫西林总体清除率的下降比克拉维酸更明显。这解释了口服给药后,随着肾小球滤过率降低,阿莫西林血浆浓度-时间曲线下面积与克拉维酸的比值增加;例如,对于GFR为75毫升/分钟,阿莫西林与克拉维酸的比值为4.9±1.2;对于GFR为35至75毫升/分钟,为5.3±2.4;对于GFR为10至35毫升/分钟,为11.9±5.8;对于GFR为5至10毫升/分钟,为13.4±9.1;对于接受血液透析的患者,为14.7±5.3。提出了剂量建议,以防止阿莫西林过度蓄积,同时维持克拉维酸的适当浓度。